GRK3 and schizophrenia: GRK3 is highly expressed in immune cells and can critically regulate immune-related behavior [22–24], while decreased RNA expression and protein levels have been observed in postmortem brain tissue obtained from schizophrenia patients [25] and polymorphisms in the GRK3 promoter have been suggested to increase the risk of bipolar disorder [26–28].